Bacillus subtilis uses the SigM signaling pathway to prioritize the use of its lipid carrier for cell wall synthesis
PLOS Biology · 2024
DOI: 10.1371/journal.pbio.3002589 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Biology, 2024. Verfasst von Ian J Roney und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Harvard Medical School, Boston, Massachusetts, United States of America. Hauptthemen laut MEDLINE: Cell Wall, Bacillus subtilis, Signal Transduction, Bacterial Proteins. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIAID NIH HHS, National Institute of General Medical Sciences.
Abstract (Originalsprache)
Peptidoglycan (PG) and most surface glycopolymers and their modifications are built in the cytoplasm on the lipid carrier undecaprenyl phosphate (UndP). These lipid-linked precursors are then flipped across the membrane and polymerized or directly transferred to surface polymers, lipids, or proteins. Despite its essential role in envelope biogenesis, UndP is maintained at low levels in the cytoplasmic membrane. The mechanisms by which bacteria distribute this limited resource among competing pathways is currently unknown. Here, we report that the Bacillus subtili s transcription factor SigM and its membrane-anchored anti-sigma factor respond to UndP levels and prioritize its use for the synthesis of the only essential surface polymer, the cell wall. Antibiotics that target virtually every step in PG synthesis activate SigM-directed gene expression, confounding identification of the signal and the logic of this stress-response pathway. Through systematic analyses, we discovered 2 distinct responses to these antibiotics. Drugs that trap UndP, UndP-linked intermediates, or precursors trigger SigM release from the membrane in
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, Harvard Medical School, Boston, Massachusetts, United States of America.
ORCID-Profile: David Z Rudner
Förderung
- NIGMS NIH HHS
- NIAID NIH HHS
- National Institute of General Medical Sciences
- Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases
Zitieren
APA
Roney, I. J., & Rudner, D. Z. (2024). Bacillus subtilis uses the SigM signaling pathway to prioritize the use of its lipid carrier for cell wall synthesis. PLOS Biology. https://doi.org/10.1371/journal.pbio.3002589
Vancouver
Roney IJ, Rudner DZ. Bacillus subtilis uses the SigM signaling pathway to prioritize the use of its lipid carrier for cell wall synthesis. PLOS Biology. 2024. doi:10.1371/journal.pbio.3002589
BibTeX
@article{Roney2024,
author = {Roney, Ian J and Rudner, David Z},
title = {Bacillus subtilis uses the SigM signaling pathway to prioritize the use of its lipid carrier for cell wall synthesis},
journal = {PLOS Biology},
year = {2024},
doi = {10.1371/journal.pbio.3002589}
}
EUVIMED